Sham-apheresis

DEVICE2 trials

Sponsors

University Hospital, Lille, University Medical Center Mainz

Conditions

End Stage Renal DiseaseMetabolic DisorderPost COVID-19 ConditionPost-COVID SyndromePost-COVID-19 SyndromeRare Diseases

Unknown Phase

Rheopheresis as Adjuvant Treatment of Calciphylaxis

RecruitingNCT04654000

University Hospital, LilleEnd Stage Renal Disease, Metabolic Disorder, Rare Diseases

Start: 2023-03-07End: 2027-05-01Target: 138Updated: 2026-02-12

Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome

CompletedNCT05841498

University Medical Center MainzPost COVID-19 Condition, Post-COVID-19 Syndrome, Post-COVID Syndrome

Start: 2023-05-08End: 2025-05-12Updated: 2025-07-28

Related Papers

Immunoadsorption study Mainz in adults with post-COVID syndrome (IAMPOCO)-a single-blinded sham-controlled crossover trial to evaluate the effect of immunoadsorption on post-COVID syndrome.

2025-04-031 citations